Skip to content
Screener

Insulet PODD Finite-Lived Intangible Assets, Accumulated Amortization

Finite-Lived Intangible Assets, Accumulated Amortization at other companies

Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$320.76M+45.4%
Medtronic logo
MedtronicMDT
InfuSystem Holdings logo
InfuSystem HoldingsINFU
AptarGroup logo
AptarGroupATR
TOI
TOITOI

Other financials

Income statement

See full
Revenue$801.7M+23.5%
Gross profit$562.6M+24.4%
Operating income$129.7M+7.1%
Net income$95.0M+322%
EPS (diluted)$1.37+328%

Balance sheet

See full
Cash & equivalents$534.9M-52.3%
Total debt$974.7M-47.6%
Total equity$1.4B-2.8%
Total assets$3.2B-8.8%

Cash flow

See full
Operating cash flow$88.4M-55.0%
CapEx$32.5M+74.7%
Free cash flow$55.9M-68.6%

Valuation

See full
Market cap$9.79B-54.4%
Enterprise value$10.23B-53.9%
P/E26.1×-64.8×
P/S3.2×-5.9×

Profitability

See full
Gross margin71.1%+0.3pp
Operating margin16.9%-0.4pp
Net margin12.3%+2.3pp
FCF margin9.6%-7.5pp

Returns & leverage

See full
Return on equity26%+6.8pp
Debt / equity0.7×-0.6×
Current ratio2.5×+0.2×

Where this comes from

Reported directly by Insulet in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.

The source filing: Insulet’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001145197-26-000169
(in millions)June 30, 2026 / Gross Carrying AmountJune 30, 2026 / Accumulated AmortizationJune 30, 2026 / Net Book ValueDecember 31, 2025 / Gross Carrying AmountDecember 31, 2025 / Accumulated AmortizationDecember 31, 2025 / Net Book Value
Customer relationships$43.1$(36.7)$6.4$43.2$(35.8)$7.4
Internal-use software76.2(20.1)56.168.3(14.1)54.2
Developed technology28.3(8.0)20.328.3(6.9)21.4
Patents44.0(11.8)32.244.0(9.9)34.2
Total intangible assets$191.6$(76.5)$115.1$183.8$(66.7)$117.1

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Insulet's finite-lived intangible assets, accumulated amortization?
Insulet (PODD) reported finite-lived intangible assets, accumulated amortization of $76.5M in Q2 2026.
How has Insulet's finite-lived intangible assets, accumulated amortization changed year-over-year?
Insulet's finite-lived intangible assets, accumulated amortization increased by 24.8% year-over-year, from $61.3M to $76.5M.
What is the long-term trend for Insulet's finite-lived intangible assets, accumulated amortization?
Over 5 years (2020 to 2025), Insulet's finite-lived intangible assets, accumulated amortization has grown at a 19.7% compound annual growth rate (CAGR), from $27.1M to $66.7M.
What does finite-lived intangible assets, accumulated amortization mean?
Finite-Lived Intangible Assets, Accumulated Amortization

Ask your AI about Insulet's finite-lived intangible assets, accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude